Investment Report on GenusPlus Group Ltd (Ticker: GNP)

Company Overview

Genus­Plus Group Ltd oper­ates in the Aus­tralian mar­ket, focus­ing on the instal­la­tion, con­struc­tion, and main­te­nance of pow­er and com­mu­ni­ca­tion sys­tems. The com­pa­ny is struc­tured into three dis­tinct seg­ments: Infra­struc­ture, Com­mu­ni­ca­tions, and Indus­tri­al. Its diverse ser­vice offer­ings include plan­ning, design­ing, con­struct­ing, oper­at­ing, test­ing, main­tain­ing, man­ag­ing, and decom­mis­sion­ing pow­er net­work assets for var­i­ous sec­tors includ­ing elec­tric­i­ty util­i­ties, telecom­mu­ni­ca­tions, and min­ing.

Key prof­it cen­tres with­in Genus­Plus encom­pass elec­tri­cal and instru­men­ta­tion ser­vices tai­lored for the min­ing, oil and gas, infra­struc­ture, and pow­er gen­er­a­tion sec­tors. The com­pa­ny also pro­vides com­pre­hen­sive engi­neer­ing and design solu­tions, high and low volt­age elec­tri­cal instal­la­tions, and asset man­age­ment ser­vices, par­tic­u­lar­ly for the resource sec­tor. More recent­ly, Genus­Plus has made strides into renew­able ener­gy, offer­ing EPC solu­tions for wind, solar, and pow­er sys­tems stor­age, enhanc­ing its mar­ket posi­tion in the bur­geon­ing green ener­gy land­scape.

Share Price Analysis

The share price of Genus­Plus at the date of analy­sis is $2.59. How­ev­er, the share price is above our intrin­sic val­ue #1, and also above our intrin­sic val­ue #2. This indi­cates the stock might be over­val­ued at the cur­rent price lev­el.

Average Daily Turnover

With an aver­age dai­ly trade of $0.392 mil­lion, Genus­Plus is clas­si­fied as a small-cap stock. This clas­si­fi­ca­tion may impact poten­tial investors regard­ing their exit strat­e­gy. Those con­sid­er­ing large parcels may find it more chal­leng­ing to liq­ui­date posi­tions with­out impact­ing the stock­’s price due to low­er trad­ing vol­umes com­pared to larg­er-cap stocks.

Dividend Yield

The div­i­dend yield is not high­er than the aver­age mort­gage rate, so it does­n’t score for this met­ric. A high­er yield than the bank debt rate is gen­er­al­ly favourable, as it indi­cates that investors could use div­i­dend income to cov­er bor­row­ing costs.

Financial Health

Genus­Plus enjoys a strong finan­cial health rat­ing, with a sta­ble trend, sug­gest­ing a sol­id man­age­ment frame­work and the abil­i­ty to weath­er eco­nom­ic fluc­tu­a­tions effec­tive­ly. This sta­bil­i­ty is cru­cial for investors seek­ing long-term growth.

Price-to-Earnings Ratio

The cur­rent PE ratio stands at 24.67. Although this met­ric does not rep­re­sent a record low over the last six report­ing peri­ods, it does pro­vide a base­line for eval­u­at­ing the com­pa­ny’s val­u­a­tion rel­a­tive to its earn­ings.

Price to Operating Cash Flow Ratio

The Price to Oper­at­ing Cash Flow ratio is 5.56, which is below our thresh­old of 7. This indi­cates that it would take approx­i­mate­ly 5.56 years for the com­pa­ny’s oper­a­tions to gen­er­ate enough cash to cov­er the stock price, which is a rea­son­able time frame.

Book Value Analysis

When eval­u­at­ing the com­pa­ny’s price in rela­tion to book val­ue, it is essen­tial to note two aspects: the stock price is high­er than the book price, and it also fails the “book plus 30%” test. Ide­al­ly, investors want to pay no more than $1.33 for every $1 of equi­ty. The cur­rent sit­u­a­tion implies a high­er risk pro­file for investors as there is no buffer mar­gin.

Earnings Growth Assessment

The Growth/PE ratio is 1.8, which is above the thresh­old of 1.5, sug­gest­ing that the com­pa­ny’s earn­ings are grow­ing at a rate that exceeds what the cur­rent PE ratio implies. This sce­nario indi­cates poten­tial under­val­u­a­tion, as the mar­ket may not ful­ly recog­nise the com­pa­ny’s growth prospects.

Ownership Structure

Sig­nif­i­cant­ly, direc­tors hold 53.82% of shares, which is con­sid­ered sub­stan­tial own­er­ship (over 10%). This lev­el of direc­tor own­er­ship sug­gests strong align­ment with share­hold­er inter­ests, enhanc­ing con­fi­dence among investors.

Market Sentiment

There has been no new 3‑point upturn not­ed recent­ly, because the sen­ti­ment has been pos­i­tive since it crossed the buy line in late 2023.

Consistency of Equity Growth

The com­pa­ny has demon­strat­ed con­sis­tent­ly increas­ing equi­ty, reflect­ing strong man­age­ment qual­i­ty and a robust oper­a­tional frame­work. This trend is a pos­i­tive indi­ca­tor for poten­tial investors.

Quality and QAV Scores

The Qual­i­ty Score stands at 73%, which is close to, but not above, our ide­al thresh­old of 75%. The QAV Score is 0.13, which is above the our cut-off thresh­old of 0.10. These scores indi­cate that the stock may present a worth­while invest­ment oppor­tu­ni­ty.

STRENGTHS

• Strong finan­cial health with a sta­ble trend.
• Poten­tial under­val­u­a­tion indi­cat­ed by Price to Oper­at­ing Cash Flow ratio.
• Direc­tors hold a sig­nif­i­cant per­cent­age of shares (53.82%), align­ing their inter­ests with share­hold­ers.
• Con­sis­tent­ly increas­ing equi­ty, sig­nalling effec­tive man­age­ment.
• Qual­i­ty Score of 73%, indi­cat­ing a high stan­dard of oper­a­tional per­for­mance.

WEAKNESSES

• Cur­rent share price is above both intrin­sic val­ues.
• Div­i­dend yield does not exceed bank debt rate.
• The share price exceeds both the book price and the book price plus 30% test, indi­cat­ing poten­tial risk.

Conclusion

In sum­ma­ry, while the val­ue met­rics are mixed, Genus­Plus Group Ltd pos­sess­es strengths that may appeal to investors. The pos­i­tive QAV score and sig­nif­i­cant direc­tor own­er­ship rein­force the com­pa­ny’s poten­tial as a rea­son­able invest­ment. The con­sis­tent equi­ty growth and strong finan­cial health fur­ther sup­port this assess­ment. Investors should con­sid­er their risk tol­er­ance and invest­ment hori­zon before mak­ing a deci­sion.

Met­ric	Val­ue
Com­pa­ny Name	Genus­Plus Group Ltd
Tick­er	GNP
Cur­rent Share Price	$2.59
Aver­age Dai­ly Trade	$0.392 mil­lion
QAV Score	0.13
Qual­i­ty Score	73%
Is Star Stock	No
Price <= Con­sen­sus Val­u­a­tion	Yes
Price <= Intrin­sic Val­ue 1	No
Price <= Intrin­sic Val­ue 2	No
Price <= Book Price + 30%	No
New 3‑point upturn	No
Growth/PE Ratio	1.8
Growth/PE > 1.5	No
Price < Book Price	No
Con­sis­tent­ly Increas­ing Equi­ty	Yes
Yield > Bank Debt Rate	No
Finan­cial Health Rat­ing	Strong
Finan­cial Health Trend	Sta­ble
Fore­cast IV > 2 x Cur­rent Share Price	No
Direc­tors Own Sig­nif­i­cant Shares	Yes
% Hold­ing of All Direc­tors	53.82%
EPS Fore­cast Year 1	15.2
PE (Price-Earn­ings Ratio)	24.67
Record Low P/E (last 6 peri­ods)	No
Price to Oper­at­ing Cash Flow	5.56
Price to Oper­at­ing Cash Flow <= 7	Yes

Dis­claimer: This pod­cast is an infor­ma­tion provider and in giv­ing you prod­uct infor­ma­tion we are not mak­ing any sug­ges­tion or rec­om­men­da­tion about a par­tic­u­lar prod­uct. The infor­ma­tion has been pre­pared with­out tak­ing into account your indi­vid­ual invest­ment objec­tives, finan­cial cir­cum­stances or needs. Before you decide whether or not to acquire a par­tic­u­lar finan­cial prod­uct you should assess whether it is appro­pri­ate for you in the light of your own per­son­al cir­cum­stances, hav­ing regard to your own objec­tives, finan­cial sit­u­a­tion and needs. You may wish to obtain finan­cial advice from a suit­ably qual­i­fied advis­er before mak­ing any deci­sion to acquire a finan­cial prod­uct. Please note that all infor­ma­tion about per­for­mance returns is his­tor­i­cal. Past per­for­mance should not be relied upon as an indi­ca­tor of future per­for­mance; unit prices and the val­ue of your invest­ment may fall as well as rise. The results are gen­er­al advice only and not per­son­al prod­uct advice.

Trans­paren­cy is impor­tant to us. We will always be very open and hon­est about the stocks we own. We will also always give our audi­ence advance notice when we intend to buy or sell a stock that we are going to talk about on the pod­cast. This is so we can nev­er be accused of pump­ing a stock to our own advan­tage. If we talk about a stock we cur­rent­ly own, we will make it known that we own it.

This email is autho­rised by Antho­ny Kynas­ton (AR No. 001292718).
Copy­right © 2022 Space­craft Pub­lish­ing Pty Ltd trad­ing as QAV (“QAV”) (ABN 41 163 119 300) which is a Cor­po­rate Autho­rised Rep­re­sen­ta­tive (CAR 001292718) of MF & Co. Asset Man­age­ment Pty Ltd (AFSL 520442).
No part of this con­tent may be repro­duced in any form with­out the pri­or con­sent of Space­craft Pub­lish­ing.